Diagnostic Imaging of Vascular Malformations Using MSOT and ULM

Launched by UNIVERSITY HOSPITAL ERLANGEN · May 28, 2025

Keywords

ClinConnect Summary

This clinical trial is studying new imaging techniques called Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) to help doctors better see and diagnose vascular malformations, which are abnormal blood vessel formations. These conditions include venous malformations, arteriovenous malformations, and lymphatic malformations. The goal is to improve the accuracy of diagnoses, which can lead to better treatment plans for patients.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of one of the types of vascular malformations mentioned. Unfortunately, those who have not undergone any imaging for diagnosis, cannot provide written consent, or have certain health concerns may not be eligible. Participants can expect to undergo non-invasive imaging tests, making the process easier and potentially more comfortable than traditional methods. This trial is not yet recruiting, so interested individuals should keep an eye out for updates on when it will begin.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed vascular malformations (arteriovenous, venous, or lymphatic).
• • ≥18 years old and able to give their consent
• Exclusion Criteria:
• • No imaging for diagnostic confirmation has been performed or is planned.
• • Lack of written consent
• • \<18 years old
• • Safety concerns of the study physician (a patient with physical, psychological, or psychiatric conditions that, in the opinion of the study physician, could compromise the patient's safety or the quality of the data, thereby making the patient an unsuitable candidate for the study).